However, PCC, in combination with ADR, reduced the viability of tumor cells more than ADR alone did; reversed the high transcript levels of Mut-p53, SP1 and MDR1 caused by ADR and increased the cell sensitivity to drugs. The gene discussed is TP53; the disease is neoplasm.